A universal and robust integrated platform for the scalable production of human cardiomyocytes from pluripotent stem cells

Stem Cells Translational Medicine

Volumn 4, Issue 12, 2015, Pages 1482-1494

  Fonoudi, Hananeh ^a,c,e   Ansari, Hassan ^a   Abbasalizadeh, Saeed ^a   Larijani, Mehran Rezaei ^a   Kiani, Sahar ^a   Hashemizadeh, Shiva ^a   Zarchi, Ali Sharifi ^a   Bosman, Alexis ^c,e   Blue, Gillian M ^g,h,i   Pahlavan, Sara ^a   Perry, Matthew ^d,e   Orr, Yishay ^g,h   Mayorchak, Yaroslav ^h   Vandenberg, Jamie ^d,e   Talkhabi, Mahmood ^a   Winlaw, David S ^g,h,i   Harvey, Richard P ^c,e,f   Aghdami, Nasser ^a   Baharvand, Hossein ^a,b  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^b UNIVERSITY OF SCIENCE AND CULTURE   (Iran)

^c Developmental and Stem Cell Biology Division   (Iran)

^d VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^e St Vincent s Clinical School   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g Kids Heart Research   (Australia)

^h CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Bioreactor; Cardiomyocytes; Cell therapy; Directed differentiation; Embryonic stem; Human pluripotent stem cells; Induced pluripotent stem; Small molecules

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; DIFFERENTIATION ANTIGEN;

ARTICLE; CARDIAC STEM CELL; CELL CULTURE; CELL LINE; CELL THERAPY; ELECTROPHYSIOLOGY; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PLURIPOTENT STEM CELL; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SKIN BIOPSY; WNT SIGNALING PATHWAY; CARDIAC MUSCLE CELL; CELL CULTURE TECHNIQUE; CELL DIFFERENTIATION; CYTOLOGY; DEVICES; INDUCED PLURIPOTENT STEM CELL; METABOLISM; PROCEDURES;

ANTIGENS, DIFFERENTIATION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCYTES, CARDIAC; WNT SIGNALING PATHWAY;

EID: 84949676048     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0275     Document Type: Article

References (49)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145–1147.
2. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917–1920.
3. Kehat I, Kenyagin-Karsenti D, Snir M et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001;108:407–414.
4. Mummery C, Ward-van Oostwaard D, Doevendans P et al. Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells. Circulation 2003;107:2733–2740.
5. Laflamme MA, Chen KY, Naumova AV et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007; 25:1015–1024.
6. Fonoudi H, Yeganeh M, Fattahi F et al. ISL1 protein transduction promotes cardiomyocyte differentiation from human embryonic stem cells. PLoS One 2013;8: e55577.
7. Zhu WZ, Hauch KD, Xu C et al. Human embryonic stem cells and cardiac repair. Transplant Rev (Orlando) 2009;23:53–68.
8. Desbordes SC, Studer L. Adapting human pluripotent stem cells to high-throughput and high-content screening. Nat Protoc 2013;8: 111–130.
9. Burridge PW, Matsa E, Shukla P et al. Chemically defined generation of human cardiomyocytes. Nat Methods 2014;11:855–860.
10. Karakikes I, Senyei GD, Hansen J et al. Small molecule-mediated directed differentiation of human embryonic stem cells toward ventricular cardiomyocytes. STEM CELLS TRANSLATIONAL MEDICINE 2014;3:18–31.
11. Zhu S, Wei W, Ding S. Chemical strategies for stem cell biology and regenerative medicine. Annu Rev Biomed Eng 2011;13:73–90.
12. Zhang Y, Li W, Laurent T et al. Small molecules, big roles—The chemical manipulation of stem cell fate and somatic cell reprogramming. J Cell Sci 2012;125:5609–5620.
13. Yuan X, Li W, Ding S. Small molecules in cellular reprogramming and differentiation. Prog Drug Res 2011;67:253–266.
14. Gonzalez R, Lee JW, Schultz PG. Stepwise chemically induced cardiomyocyte specification of human embryonic stem cells. Angew Chem Int Ed Engl 2011;50:11181–11185.
15. Lian X, Hsiao C, Wilson G et al. Robust cardiomyocytedifferentiationfromhumanpluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci USA 2012;109: E1848–E1857.
16. Minami I, Yamada K, Otsuji TG et al. A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. Cell Reports 2012;2:1448–1460.
17. Chen VC, Couture SM, Ye J et al. Scalable GMP compliant suspension culture system for human ES cells. Stem Cell Res (Amst) 2012;8: 388–402.
18. Singh H, Mok P, Balakrishnan T et al. Upscaling single cell-inoculated suspension culture of human embryonic stem cells. Stem Cell Res (Amst) 2010;4:165–179.
19. Lecina M, Ting S, Choo A et al. Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures. Tissue Eng Part C Methods 2010;16:1609–1619.
20. Niebruegge S, Bauwens CL, Peerani R et al. Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor. Biotechnol Bioeng 2009;102:493–507.
21. Bauwens CL, Song H, Thavandiran N et al. Geometric control of cardiomyogenic induction in human pluripotent stem cells. Tissue Eng Part A 2011;17:1901–1909.
22. Hwang YS, Chung BG, Ortmann D et al. Microwell-mediated control of embryoid body size regulatesembryonic stemcell fate via differential expression of WNT5a and WNT11. Proc Natl Acad Sci USA 2009;106:16978–16983.
23. Nguyen DC, Hookway TA, Wu Q et al. Microscale generation of cardiospheres promotes robust enrichment of cardiomyocytes derived from human pluripotent stem cells. Stem Cell Rep 2014;3:260–268.
24. Kempf H, Olmer R, Kropp C et al. Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture. Stem Cell Rep 2014;3:1132–1146.
25. Hemmi N, Tohyama S, Nakajima K et al. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes. STEM CELLS TRANSLATIONAL MEDICINE 2014;3:1473–1483.
26. O’Brien C, Laslett AL. Suspendedinculture—Human pluripotent cells for scalable technologies. Stem Cell Res (Amst) 2012;9:167–170.
27. Abbasalizadeh S, Larijani MR, Samadian A et al. Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor. Tissue Eng Part C Methods 2012;18:831–851.
28. Vosough M, Omidinia E, Kadivar M et al. Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture. Stem Cells Dev 2013;22:2693–2705.
29. Tohyama S, Hattori F, Sano M et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 2013;12:127–137.
30. Baharvand H, Ashtiani SK, Taee A et al. Generation of new human embryonic stem cell lines with diploid and triploid karyotypes. Dev Growth Differ 2006;48:117–128.
31. Taei A, Hassani SN, Eftekhari-Yazdi P et al. Enhanced generation of human embryonic stem cells from single blastomeres of fair and poor-quality cleavage embryos via inhibition of glycogen synthase kinase b and Rho-associated kinase signaling.HumReprod 2013;28:2661–2671.
32. Larijani MR, Seifinejad A, Pournasr B et al. Long-term maintenance of undifferentiated human embryonic and induced pluripotent stemcells in suspension. Stem Cells Dev 2011;20:1911–1923.
33. Ihaka R, Gentleman RR. A language and environment for statistical computing. J Comput Graph Stat 1996;5:299–314.
34. Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer, 2009.
35. Asakura K, Hayashi S, Ojima A et al. Improvement of acquisition and analysis methods in multi-electrode array experiments with iPS cell-derived cardiomyocytes. J Pharmacol Toxicol Methods 2015 [Epub ahead of print].
36. Fatima A, Xu G, Shao K et al. In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells. Cell Physiol Biochem 2011;28:579–592.
37. Fatima A, Kaifeng S, Dittmann S et al. The disease-specific phenotype in cardiomyocytes derived from induced pluripotent stem cells of two long QT syndrome type 3 patients. PLoS One 2013;8:e83005.
38. Serra M, Brito C, Correia C et al. Process engineering of humanpluripotent stem cells for clinical application. Trends Biotechnol 2012;30: 350–359.
39. Ueno S, Weidinger G, Osugi T et al. Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci USA 2007;104: 9685–9690.
40. Blauwkamp TA, Nigam S, Ardehali R et al. EndogenousWnt signalling in human embryonic stem cells generates an equilibrium of distinct lineage-specified progenitors. Nat Commun 2012;3:1070.
41. Burridge PW, Anderson D, Priddle H et al. Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability. STEM CELLS 2007;25: 929–938.
42. Mohr JC, Zhang J, Azarin SM et al. The microwell control of embryoid body size in order to regulate cardiac differentiation of human embryonic stem cells. Biomaterials 2010;31: 1885–1893.
43. Correia C, Serra M, Espinha N et al. Combining hypoxia and bioreactor hydrodynamics boosts induced pluripotent stem cell differentiation towards cardiomyocytes. Stem Cell Rev 2014;10:786–801.
44. Schwartz SD, Hubschman JP, Heilwell G et al. Embryonic stem cell trials for macular degeneration: A preliminary report. Lancet 2012; 379:713–720.
45. Schwartz SD, Regillo CD, Lam BL et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with agerelatedmacular degeneration and Stargardt’s macular dystrophy: Follow-up of two openlabel phase 1/2 studies. Lancet 2015;385: 509–516.
46. Song WK, Park KM, Kim HJ et al. Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: Preliminary results in Asian patients. Stem Cell Rep 2015;4:860–872.
47. Reardon S, Cyranoski D. Japan stem-cell trial stirs envy. Nature 2014;513:287–288.
48. Sallam K, Kodo K, Wu JC. Modeling inherited cardiac disorders. Circ J 2014;78: 784–794.
49. Dell’Era P, Benzoni P, Crescini E et al. Cardiac diseasemodeling using induced pluripotent stemcell-derived human cardiomyocytes.World J Stem Cells 2015;7:329–342.